Management of suspected hypersensitivity reactions to anti-TB drugs
Int J Tuberc Lung Dis
.
2023 Jul 1;27(7):570-573.
doi: 10.5588/ijtld.23.0103.
Authors
L Mutlu
1
,
W H Bermingham
1
,
O E Mohamed
1
,
C Melchior
1
,
L Samuel
1
,
J Heslegrave
1
,
R Baretto
1
,
A Ekbote
1
,
A Huissoon
1
,
M Dedicoat
2
,
M T Krishna
3
Affiliations
1
Department of Allergy and Immunology, Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
2
Infectious Diseases Department, Birmingham Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK.
3
Department of Allergy and Immunology, Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK.
PMID:
37353875
DOI:
10.5588/ijtld.23.0103
No abstract available
MeSH terms
Antitubercular Agents* / adverse effects
Drug Hypersensitivity* / therapy
Humans
Skin Tests
Substances
Antitubercular Agents